Skip to Content

Research & Funding

Past Other NCI & NIH InitiativesRSS

This page lists past other NCI and NIH cancer imaging initiatives, including grant mechanisms.

Requests for Application (RFA) are usually announced with special application dates; there is no possibility for applying after that date. Program Announcements (PA, PAR) may be open for a set period of time, such as 3 years or less; applications submitted in response to Program Announcements may be due on the standard dates (February 1, June1, and October 1) or may have special dates for receipt of applications. Please pay attention to these dates. Contact a CIP staff member if you have questions.

  • PAR-13-174: Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)

    • Release Date: May 14, 2013
    • Application Receipt Date: July 10, 2013
    • Expiration Date: July 11, 2013
    • Contacts:

      Richard Mazurchuk, Ph.D.; Phone 240-276-7126; Email: mazurchukrv@mail.nih.gov

      Imaging related: Keyvan Farahani, Ph.D.; Phone: 240-276-5921; Email: farahank@mail.nih.gov

    This Funding Opportunity Announcement (FOA) invites revision applications from currently funded SPORE or ICMIC Specialized Centers using the NCI P50 grant mechanism. Revision applications are expected to focus on combined imaging and biomarker approaches to improve screening, early cancer detection and diagnosis by integrating multi modality imaging strategies and multiplexed biomarker methodologies. Depending on the context and focus of the parent P50 award, studies proposed in the revision application must correspond to an additional project expanding the scope of the parent Program Project while maintaining relevance to the overall focus of the parent grant.

  • PAR-13-175: Revision Applications to P01 Awards for Research on Imaging and biomarkers for Early Cancer Detection (P01)

    • Release Date: May 14, 2013
    • Application Receipt Date: July 10, 2013
    • Expiration Date: July 11, 2013
    • Contacts:

      Richard Mazurchuk, Ph.D.; Phone 240-276-7126; Email: mazurchukrv@mail.nih.gov

      Imaging related: Keyvan Farahani, Ph.D.; Phone: 240-276-5921; Email: farahank@mail.nih.gov

    This Funding Opportunity Announcement (FOA) invites revision applications from currently funded NIH P01 program projects. Revision applications are expected to focus on combined imaging and biomarker approaches to improve screening, early cancer detection and diagnosis by integrating multi modality imaging strategies and multiplexed biomarker methodologies. Depending on the context and focus of the parent P01 award, studies proposed in the revision application must correspond to an additional project expanding the scope of the parent Program Project while maintaining relevance to the overall focus of the parent grant.

  • DE-FOA-0000646: Integrated Nuclear Medicine Research and Training Projects of Excellence

    • Release Date: January 20, 2012
    • Application Receipt Date: Pre-Application (Required) Due Date: February 23, 2012
      Application Due Date: March 28, 2012
    • Expiration Date: March 28, 2012
    • Contacts:

      Dr. Prem Srivastava, Office of Biological and Environmental Research; Tel. 301-903-4071; prem.srivastava@science.doe.gov

    This Funding Opportunity aims to serve three important goals:

    1. Research and development of new and highly innovative radiotracer methods and radiotracers as potential imaging agents for nuclear medicine research and application to advance the understanding of normal human physiology and gene expression, diagnosis and management of disease, in drug research and development, and in translational science;
    2. Integrated involvement of  postdoctoral fellows (Ph.D. radiochemists) and M.D., or M.D.-Ph.D fellows with specialties in Nuclear Medicine with applications to human health in developing and deploying new radiotracers for nuclear medicine imaging and potential clinical use in humans for disease-specific application;
    3. Enhancement of training opportunities to ensure the future availability of human resources for highly specialized fields of radiotracer development chemistry and clinical nuclear medicine research and allied disciplines.

    Pre-Application is Required. Pre-Application Due Date:  February 23, 2012

  • CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE (R01) (MULTIPLE IC'S) (PAR-11-028)

    • Release Date: November 12, 2010
    • Application Receipt Date: Standard dates apply
    • Expiration Date: January 8, 2014
    • Contacts:

      Jerry Li, Ph.D.; Tel. 240-276-6210; E-mail: jiayinli@mail.nih.gov

    • Letter of Intent Receipt Date: Not applicable

    This Funding Opportunity Announcement is aimed at satisfying one of the needs created by the parallel achievements and increased interdependence of the biological and computing sciences. This interdependence offers an unprecedented opportunity for sophisticated approaches to computer-enabled research in the biological, clinical, and behavioral sciences. The purpose of this program announcement is to assure the availability and continued usefulness of existing biomedical informatics/computational biology software. This program announcement is meant for existing software that serves a biological, clinical, or behavioral community of users. Applications under this program announcement can seek support to improve the existing software in several different ways listed below. Any of these improvements should benefit the existing user community and/or have high potential for attracting significantly more users.

    See full description in NIH Guide: PAR-11-028.

  • PAR-10-234: Bioengineering Research Partnerships (BRP) [R01] (Multiple ICs)

    • Release Date: July 27, 2010
    • Application Receipt Date: Standard dates
    • Expiration Date: September 8, 2013
    • Contacts:

      Albert Lee, Ph.D., NIBIB, Phone: 301-451-4781, Email: alee@mail.nih.gov

    Participating Institutes and Centers (ICs) of the NIH invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological, clinical, or biomedical research problems. In the context of this program, a partnership is a multi-disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior.

    See full description in NIH Guide: PAR-10-234

  • DEVELOPMENT OF ASSAYS FOR HIGH-THROUGHPUT DRUG SCREENING (NIDDK, NCI, NIAID, NIMH) (R01) (PA-10-213)

    • Release Date: June 10, 2010
    • Application Receipt Date: Standard Dates
    • Expiration Date: September 8, 2013
    • Contacts:

      Robert G Lees, Ph.D., NCI, Phone: 301-496-8783, Email: leesro@mail.nih.gov

    The purpose of this FOA is to stimulate the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to the mission of the institutes involved, with the intent of using the assays to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads.

    NCI:Assays pertinent to the mission of NCI should be justified in the application as relevant to cancer. The NCI is interested in development of assays to identify or evaluate small molecules for use in elucidating molecular, cellular, or in vivo mechanisms or processes of probable or known importance to cancer biology, and for use in developing strategies for cancer prevention, diagnosis, treatment or clinical monitoring of treatment. Assays proposed may be biochemical, cellular or model organism-based, and may be useful for discovering small molecule probes, preventive or therapeutic drug leads, or imaging agent leads. Applicants may find the NCI Developmental Therapeutics Program () resources to be helpful. Collaborations between laboratories with screen development capabilities and laboratories with small molecule synthesis capabilities are encouraged.

    See full description in NIH Guide: PA-10-213

  • Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (F32) (PA-10-110)

    The objective of NIH-supported Ruth L. Kirschstein National Research Service Awards programs is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation's biomedical, behavioral, and clinical research needs.

    The purpose of the postdoctoral fellowship (F32) award is to provide support to promising postdoctoral applicants who have the potential to become productive and successful independent research investigators. The proposed postdoctoral training must offer an opportunity to enhance the applicant's understanding of the health-related sciences, and must be within the broad scope of biomedical, behavioral, or clinical research or other specific disciplines relevant to the research mission of the participating NIH Institutes and Centers. Applicants with a health professional doctoral degree may use the proposed postdoctoral training to satisfy a portion of the degree requirements for a master's degree, a research doctoral degree or any other advanced research degree program.

    The NRSA legislation requires that the Nation's overall needs for biomedical research personnel be taken into account by giving special consideration to physicians and other health professionals who propose to become active biomedical researchers and who agree to undertake a minimum of 2 years of biomedical, behavioral or clinical research. Individuals from diverse racial and ethnic groups and individuals with disabilities and individuals from disadvantaged backgrounds are always encouraged to apply for NIH support.

    Each NIH Institute and Center (IC) has a unique scientific purview and different program goals and initiatives that evolve over time. Prospective Fellowship Applicants are encouraged to contact the relevant NIH staff for IC-specific programmatic information: Table of Institute and Center Contacts.

    URL: http://grants.nih.gov/grants/guide/pa-files/PA-10-110.html

  • Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (F33) (PA-10-111)

    • Application Receipt/Submission Date(s): Multiple dates, see announcement.

    The National Institutes of Health (NIH) awards individual senior level research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. The primary objective of this funding opportunity is to help ensure that diverse pools of highly trained scientists will be available in adequate numbers and in appropriate research areas to carry out the Nation's biomedical, behavioral and clinical research agendas.

    URL: http://grants.nih.gov/grants/guide/pa-files/PA-10-111.html

  • Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research (PA-10-109)

    The Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research will provide up to five years of support for research training leading to the Ph.D. or equivalent research degree, the combined M.D./Ph.D. degree; or another formally combined professional degree and research doctoral degree in biomedical, behavioral, health services, or clinical sciences. These fellowships will enhance the diversity of the biomedical, behavioral, health services, and clinical research labor force in the United States by providing opportunities for academic institutions to identify and recruit students from diverse population groups to seek graduate degrees in health-related research and apply for this fellowship. The overall goal of this program is to increase the number of scientists from diverse population groups who are prepared to pursue careers in biomedical, behavioral, social, clinical, or health services research.

    URL: http://grants.nih.gov/grants/guide/pa-files/PA-10-109.html

  • PA-10-063: NIH Pathway to Independence (PI) Award (K99/R00)

    • Release Date: December 16, 2009
    • Application Receipt Date: standard dates
    • Expiration Date: January 8, 2013
    • Contacts:

      Nancy C. Lohrey, MS, MT-ASCP, NCI, Phone: 301-496-8580, Email: LohreyN@mail.nih.gov

    The primary purpose of the Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information.

    The K99/R00 program must be tailored to meet the individual needs of the candidate. Candidates may request up to 5 years of support consisting of two phases. The initial phase will provide 1-2 years of mentored support for highly promising, postdoctoral research scientists. This phase will be followed by up to 3 years of independent support contingent on securing an independent tenure-track or equivalent research position. R00 award recipients are expected to apply for additional NIH or other independent research grant support during the independent phase of the award.

    Grants awarded by NCI under this announcement will be funded as Howard Temin Pathway to Independence Awards in Cancer Research.

    The candidate's research proposal must be laboratory-based and must include research on the etiology, pathogenesis, prevention, diagnosis, control or treatment of HUMAN cancer. The proposed research may involve model systems, including animal models. However, at some point during the grant period, the proposed research must include work on human cancer (includes human cancer cells or tissues).

    Candidates must be able to identify an individual with extensive experience in human cancer research who can serve as a mentor for the initial mentored phase of this award.

    See full description in NIH Guide: PA-10-063